These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 9366526

  • 1. MCF-7 breast carcinoma cells overexpressing FGF-1 form vascularized, metastatic tumors in ovariectomized or tamoxifen-treated nude mice.
    Zhang L, Kharbanda S, Chen D, Bullocks J, Miller DL, Ding IY, Hanfelt J, McLeskey SW, Kern FG.
    Oncogene; 1997 Oct 23; 15(17):2093-108. PubMed ID: 9366526
    [Abstract] [Full Text] [Related]

  • 2. Both autocrine and paracrine effects of transfected acidic fibroblast growth factor are involved in the estrogen-independent and antiestrogen-resistant growth of MCF-7 breast cancer cells.
    Zhang L, Kharbanda S, Hanfelt J, Kern FG.
    Cancer Res; 1998 Jan 15; 58(2):352-61. PubMed ID: 9443417
    [Abstract] [Full Text] [Related]

  • 3. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells.
    Ruohola JK, Viitanen TP, Valve EM, Seppänen JA, Loponen NT, Keskitalo JJ, Lakkakorpi PT, Härkönen PL.
    Cancer Res; 2001 May 15; 61(10):4229-37. PubMed ID: 11358849
    [Abstract] [Full Text] [Related]

  • 4. Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice.
    McLeskey SW, Kurebayashi J, Honig SF, Zwiebel J, Lippman ME, Dickson RB, Kern FG.
    Cancer Res; 1993 May 01; 53(9):2168-77. PubMed ID: 8481920
    [Abstract] [Full Text] [Related]

  • 5. Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ.
    Kurebayashi J, McLeskey SW, Johnson MD, Lippman ME, Dickson RB, Kern FG.
    Cancer Res; 1993 May 01; 53(9):2178-87. PubMed ID: 8481921
    [Abstract] [Full Text] [Related]

  • 6. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
    Osborne CK, Hobbs K, Clark GM.
    Cancer Res; 1985 Feb 01; 45(2):584-90. PubMed ID: 3967234
    [Abstract] [Full Text] [Related]

  • 7. Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors.
    McLeskey SW, Zhang L, El-Ashry D, Trock BJ, Lopez CA, Kharbanda S, Tobias CA, Lorant LA, Hannum RS, Dickson RB, Kern FG.
    Clin Cancer Res; 1998 Mar 01; 4(3):697-711. PubMed ID: 9533540
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of fibroblast growth factor 1 in MCF-7 breast cancer cells facilitates tumor cell dissemination but does not support the development of macrometastases in the lungs or lymph nodes.
    Zhang L, Kharbanda S, McLeskey SW, Kern FG.
    Cancer Res; 1999 Oct 01; 59(19):5023-9. PubMed ID: 10519418
    [Abstract] [Full Text] [Related]

  • 9. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
    Chen J, Power KA, Mann J, Cheng A, Thompson LU.
    Exp Biol Med (Maywood); 2007 Sep 01; 232(8):1071-80. PubMed ID: 17720953
    [Abstract] [Full Text] [Related]

  • 10. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ, Raney S.
    Cell Biol Int; 1998 Sep 01; 22(6):413-9. PubMed ID: 10328849
    [Abstract] [Full Text] [Related]

  • 11. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
    Johnston SR, Boeddinghaus IM, Riddler S, Haynes BP, Hardcastle IR, Rowlands M, Grimshaw R, Jarman M, Dowsett M.
    Cancer Res; 1999 Aug 01; 59(15):3646-51. PubMed ID: 10446976
    [Abstract] [Full Text] [Related]

  • 12. Transforming growth factor beta 1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice.
    Arteaga CL, Carty-Dugger T, Moses HL, Hurd SD, Pietenpol JA.
    Cell Growth Differ; 1993 Mar 01; 4(3):193-201. PubMed ID: 8466857
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fibroblast growth factor overexpressing breast carcinoma cells as models of angiogenesis and metastasis.
    McLeskey SW, Zhang L, Kharbanda S, Kurebayashi J, Lippman ME, Dickson RB, Kern FG.
    Breast Cancer Res Treat; 1996 Mar 01; 39(1):103-17. PubMed ID: 8738610
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis.
    Weinstat-Saslow DL, Zabrenetzky VS, VanHoutte K, Frazier WA, Roberts DD, Steeg PS.
    Cancer Res; 1994 Dec 15; 54(24):6504-11. PubMed ID: 7527299
    [Abstract] [Full Text] [Related]

  • 20. EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity.
    Lu M, Miller KD, Gokmen-Polar Y, Jeng MH, Kinch MS.
    Cancer Res; 2003 Jun 15; 63(12):3425-9. PubMed ID: 12810680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.